These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9214508)
21. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717 [TBL] [Abstract][Full Text] [Related]
23. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4. Morén A; Itoh S; Moustakas A; Dijke P; Heldin CH Oncogene; 2000 Sep; 19(38):4396-404. PubMed ID: 10980615 [TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848 [TBL] [Abstract][Full Text] [Related]
25. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Zhang Y; Musci T; Derynck R Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310 [TBL] [Abstract][Full Text] [Related]
26. Sedimentation studies reveal a direct role of phosphorylation in Smad3:Smad4 homo- and hetero-trimerization. Correia JJ; Chacko BM; Lam SS; Lin K Biochemistry; 2001 Feb; 40(5):1473-82. PubMed ID: 11170475 [TBL] [Abstract][Full Text] [Related]
27. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Shioda T; Lechleider RJ; Dunwoodie SL; Li H; Yahata T; de Caestecker MP; Fenner MH; Roberts AB; Isselbacher KJ Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9785-90. PubMed ID: 9707553 [TBL] [Abstract][Full Text] [Related]
28. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283 [TBL] [Abstract][Full Text] [Related]
29. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas]. Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795 [TBL] [Abstract][Full Text] [Related]
30. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020 [TBL] [Abstract][Full Text] [Related]
31. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Kuang C; Chen Y Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410 [TBL] [Abstract][Full Text] [Related]
32. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Jonson T; Gorunova L; Dawiskiba S; Andrén-Sandberg A; Stenman G; ten Dijke P; Johansson B; Höglund M Genes Chromosomes Cancer; 1999 Jan; 24(1):62-71. PubMed ID: 9892110 [TBL] [Abstract][Full Text] [Related]
34. Role of Smad4 (DPC4) inactivation in human cancer. Miyaki M; Kuroki T Biochem Biophys Res Commun; 2003 Jul; 306(4):799-804. PubMed ID: 12821112 [TBL] [Abstract][Full Text] [Related]
35. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019 [TBL] [Abstract][Full Text] [Related]
36. The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling. Das P; Maduzia LL; Wang H; Finelli AL; Cho SH; Smith MM; Padgett RW Development; 1998 Apr; 125(8):1519-28. PubMed ID: 9502733 [TBL] [Abstract][Full Text] [Related]
37. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. de Caestecker MP; Yahata T; Wang D; Parks WT; Huang S; Hill CS; Shioda T; Roberts AB; Lechleider RJ J Biol Chem; 2000 Jan; 275(3):2115-22. PubMed ID: 10636916 [TBL] [Abstract][Full Text] [Related]
39. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Yanagisawa K; Uchida K; Nagatake M; Masuda A; Sugiyama M; Saito T; Yamaki K; Takahashi T; Osada H Oncogene; 2000 May; 19(19):2305-11. PubMed ID: 10822381 [TBL] [Abstract][Full Text] [Related]
40. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]